Alphatec Shares Plunge 32% to 52-Week Low After Full-Year Revenue Outlook Cut
ATEC is trading near its 52-week low of $6.85 (2.8% above the low) on elevated volume (4.1× avg).
Summary
Alphatec Holdings' shares plummeted 32% to a new 52-week low after the company lowered its full-year revenue outlook to approximately $882 million from previous guidance of $890 million. This significant market reaction follows the company's Q1 earnings report yesterday, which also revealed a miss on analyst estimates for both revenue and earnings per share, alongside declining sales of its EOS imaging systems and a 3% year-over-year drop in revenue per case. While the absolute reduction in guidance is modest, the severe stock decline indicates deep market concern over the company's growth trajectory and the performance of key product lines. Traders will closely monitor future updates on EOS imaging system sales and any strategic adjustments to address the revenue per case decline.
At the time of this announcement, ATEC was trading at $7.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $6.85 to $23.29. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.